Clinical Trials Update: Nov. 21, 2003
Rheumatoid Arthritis Post Menopause Diabetes - Type II
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A study of an investigational medication that may decrease joint pain and swelling, and slow the progression of joint damage caused by rheumatoid arthritis. Volunteers 18 or older who have been diagnosed with rheumatoid arthritis and have been taking the same dose of Methotrexate for at least the last two months may be eligible. Research site located in Oklahoma City, Ok.
A study to test an investigational drug to treat feminine dryness, itching, urinary discomfort or pain during intercourse. Female volunteers at least 50 years old who have been postmenopausal for at least three years and are not currently using any type of hormone therapy may be eligible. Research site located in Columbus, Ohio.
Diabetes - Type II
A research study of an investigational medication for Type 2 diabetes. Volunteers between 18 and 70 who are not taking any diabetic medication and are non-asthmatic may be eligible. Research site located in Salt Lake City, Ut.
Copyright 2003 CenterWatch. All rights reserved.